Literature DB >> 15206924

A novel four transmembrane spanning protein, CLP24. A hypoxically regulated cell junction protein.

Jonathan Kearsey1, Silvere Petit, Catherine De Oliveira, Fabien Schweighoffer.   

Abstract

A novel hypoxically regulated intercellular junction protein (claudin-like protein of 24 kDa, CLP24) has been identified that shows homology to the myelin protein 22/epithelial membrane protein 1/claudin family of cell junction proteins, which are involved in the modulation of paracellular permeability. The CLP24 protein contains four predicted transmembrane domains and a C-terminal protein-protein interaction domain. These domains are characteristic of the four transmembrane spanning (tetraspan) family of proteins, which includes myelin protein 22, and are involved in cell adhesion at tight, gap and adherens junctions. Expression profiling analyses show that CLP24 is highly expressed in lung, heart, kidney and placental tissues. Cellular studies confirm that the CLP24 protein localizes to cell-cell junctions and co-localizes with the beta-catenin adherens junction-associated protein but not with tight junctions. Over-expression of CLP24 results in decreased adhesion between cells, and functional paracellular flux studies confirm that over-expression of the CLP24 protein modulates the junctional barrier function. These data therefore suggest that CLP24 is a novel, hypoxically regulated tetraspan adherens junction protein that modulates cell adhesion, paracellular permeability and angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15206924     DOI: 10.1111/j.1432-1033.2004.04186.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  10 in total

1.  Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease.

Authors:  Susan K Murphy; Hyuna Yang; Cynthia A Moylan; Herbert Pang; Andrew Dellinger; Manal F Abdelmalek; Melanie E Garrett; Allison Ashley-Koch; Ayako Suzuki; Hans L Tillmann; Michael A Hauser; Anna Mae Diehl
Journal:  Gastroenterology       Date:  2013-07-31       Impact factor: 22.682

Review 2.  Physiology and function of the tight junction.

Authors:  James M Anderson; Christina M Van Itallie
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-08       Impact factor: 10.005

Review 3.  Claudins and the kidney.

Authors:  Jianghui Hou; Madhumitha Rajagopal; Alan S L Yu
Journal:  Annu Rev Physiol       Date:  2012-11-05       Impact factor: 19.318

4.  Claudin-like protein 24 interacts with the VEGFR-2 and VEGFR-3 pathways and regulates lymphatic vessel development.

Authors:  Pipsa Saharinen; Hanna Helotera; Juho Miettinen; Camilla Norrmen; Gabriela D'Amico; Michael Jeltsch; Tobias Langenberg; Wouter Vandevelde; Annelii Ny; Mieke Dewerchin; Peter Carmeliet; Kari Alitalo
Journal:  Genes Dev       Date:  2010-05       Impact factor: 11.361

5.  A missense mutation in the previously undescribed gene Tmhs underlies deafness in hurry-scurry (hscy) mice.

Authors:  Chantal M Longo-Guess; Leona H Gagnon; Susan A Cook; Jian Wu; Qing Y Zheng; Kenneth R Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-19       Impact factor: 11.205

6.  Expression and prognostic potential of TMEM204: a pan-cancer analysis.

Authors:  Zicheng Zhen; Minghao Li; Muyan Zhong; Jiaqi Liu; Wendu Huang; Liqun Ye
Journal:  Int J Clin Exp Pathol       Date:  2022-07-15

7.  Targeted knockout and lacZ reporter expression of the mouse Tmhs deafness gene and characterization of the hscy-2J mutation.

Authors:  Chantal M Longo-Guess; Leona H Gagnon; Bernd Fritzsch; Kenneth R Johnson
Journal:  Mamm Genome       Date:  2007-09-18       Impact factor: 2.957

8.  Hypoxia disrupts the barrier function of neural blood vessels through changes in the expression of claudin-5 in endothelial cells.

Authors:  Takashi Koto; Keiyo Takubo; Susumu Ishida; Hajime Shinoda; Makoto Inoue; Kazuo Tsubota; Yasunori Okada; Eiji Ikeda
Journal:  Am J Pathol       Date:  2007-04       Impact factor: 4.307

9.  Integrative genome-wide gene expression profiling of clear cell renal cell carcinoma in Czech Republic and in the United States.

Authors:  Magdalena B Wozniak; Florence Le Calvez-Kelm; Behnoush Abedi-Ardekani; Graham Byrnes; Geoffroy Durand; Christine Carreira; Jocelyne Michelon; Vladimir Janout; Ivana Holcatova; Lenka Foretova; Antonin Brisuda; Fabienne Lesueur; James McKay; Paul Brennan; Ghislaine Scelo
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

10.  Serum-based microRNA signature predicts relapse and therapeutic outcome of adjuvant chemotherapy in colorectal cancer patients.

Authors:  Dengbo Ji; Meng Qiao; Yunfeng Yao; Ming Li; Hailong Chen; Qi Dong; Jinying Jia; Xinxin Cui; Zhaowei Li; Jinhong Xia; Jin Gu
Journal:  EBioMedicine       Date:  2018-08-27       Impact factor: 8.143

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.